PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Osteoporosis treatment benefits people older than 80

Medication reduces hospitalization, mortality risk among older patients

2025-07-12
(Press-News.org) SAN FRANCISCO—People who are older than 80 should be considered for osteoporosis treatment after a fracture to avoid further risk, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.

“The burden of osteoporosis is rising as the global population ages rapidly,” said Gianina Flocco, M.D., a resident at the Cleveland Clinic in Cleveland, Ohio. “Our study supports the initiation of osteoporosis treatment after a fracture in people older than 80 years, as it has been shown to decrease both hospitalization and mortality.”

Flocco and colleagues used the TriNextX health research database to study 88,676 patients aged 80 and older who suffered a fracture due to bone deterioration or weakness caused by osteoporosis.

The patients were segmented into two groups. The first included 44,338 patients who were treated with bisphosphonates, denosumab, raloxifene or teriparatide. The second group had the same number of patients, but included those who didn’t receive any osteoporosis treatments.

Patients were followed for 5 years after the initial fracture. The research accounted for comorbidities, including hypertension, diabetes, ischemic heart disease, obesity, heart failure, stroke, COPD, chronic kidney disease, hyperlipidemia, rheumatoid arthritis, neoplasm and vitamin D deficiency.

The patients in the treatment group experienced a lower risk of hospitalization. This group also experienced lower all-cause mortality.

Flocco said that the burden of osteoporosis is expected to increase in the future. These study results support their suggestion to treat older patients who are most vulnerable to fractures as they continue to age.

“The results of our study support the need to enhance the individualized initiation of treatment of osteoporosis, even in people who are older than 80”, she said. “Treating people to reduce the burden of osteoporosis complications, like fractures leading to disability or death, would play a significant role in improving health span in the growing older population.”
 

# # #
 

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions. 

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.

END



ELSE PRESS RELEASES FROM THIS DATE:

Consuming more protein may protect patients taking anti-obesity drug from muscle loss

2025-07-12
SAN FRANCISCO—Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. Losing muscle (or lean mass) is a common side effect of weight loss in adults with obesity and may negatively affect metabolism and bone health. This is because muscle helps control blood sugar after meals and plays an important role in keeping bones strong, according to study lead researcher Melanie Haines, M.D., of Massachusetts ...

Thyroid treatment may improve gut health in people with hypothyroidism

2025-07-12
SAN FRANCISCO—People with an underactive thyroid may have an increased risk of developing small intestinal bacterial overgrowth (SIBO), a risk that may be reduced with thyroid hormone treatment, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. “We now know that people with hypothyroidism, especially those with autoimmune thyroiditis, are more likely to develop SIBO, but this risk appear to be mitigated in those taking thyroid medications,” said Ruchi Mathur, M.D., Director of the Diabetes Outpatient ...

Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss

2025-07-12
SAN FRANCISCO—Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. “These data are the first to show the combined use of tirzepatide and menopause hormone therapy significantly increases treatment effectiveness in postmenopausal women,” said Regina Castaneda, ...

High blood sugar may have a negative impact on men’s sexual health

2025-07-12
SAN FRANCISCO—Metabolic health factors, including small increases in blood sugar, are the main drivers of change in the reproductive systems and sexual functioning of aging men, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. “Although age and testosterone levels have long been considered an impetus for men’s declining sexual health, our research indicates that these changes more closely correlate with modest increases in blood sugar and other metabolic changes,” said Michael Zitzmann, ...

Emotional health of parents tied to well-being of children with growth hormone deficiency

2025-07-12
SAN FRANCISCO—Strong emotional links between children with chronic conditions and their family caregivers suggest that improving parent well-being may directly benefit a child’s overall health and coping mechanisms, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. The study observed children with growth hormone deficiency and their caregivers to better understand the impact that physical or emotional distress can have. Findings suggest that when parents or caregivers of children with growth hormone deficiency report symptoms of stress, anxiety and depression, so does the child they ...

Oxytocin may reduce mood changes in women with disrupted sleep

2025-07-12
SAN FRANCISCO—Oxytocin, often called “the love hormone,” may play a protective role in mood disturbances triggered by sleep loss and hormonal shifts during key reproductive transitions like postpartum and menopause, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. Researchers at Brigham and Women’s Hospital and Harvard Medical School studied the combined impact of sleep interruption and estrogen suppression on mood and oxytocin levels in healthy premenopausal women. Their findings suggest that oxytocin may help reduce the negative mood effects brought on by fragmented sleep, which ...

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

2025-07-12
SAN FRANCISCO—The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. "Obesity is a significant risk factor for breast cancer, and while it is very preliminary data, our studies in mice suggest that these new anti-obesity drugs may be a way to reduce obesity-associated breast cancer risk or improve outcomes,” said study author Amanda Kucinskas, ...

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

2025-07-11
https://doi.org/10.1016/j.apsb.2025.05.003 This new article publication from Acta Pharmaceutica Sinica B, discusses how a CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury.   Acute liver injury (ALI) serves as a critical precursor and major etiological factor in the progression and ultimate manifestation of various hepatic disorders. The prevention and treatment of ALI is still a serious global challenge. Given the limited therapeutic options for ALI, exploring novel targeted therapeutic agents becomes imperative. The potential therapeutic ...

Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1

2025-07-11
https://doi.org/10.1016/j.apsb.2025.05.018 This new article publication from Acta Pharmaceutica Sinica B, discusses how melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1.   A major obstacle in type 2 diabetes mellitus (T2DM) is sleep fragmentation (SF), which negatively affects testicular function. However, the underlying mechanisms remain to be elucidated. This study demonstrated that SF induces testicular damage through a mechanism involving lipid metabolism, ...

Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce

2025-07-11
https://doi.org/10.1016/j.apsb.2025.05.013 This new article publication from Acta Pharmaceutica Sinica B, discusses how single-cell RNA sequencing reveals that Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic cells.   Colorectal tumorigenesis generally progresses from adenoma to adenocarcinoma, accompanied by dynamic changes in the tumor microenvironment (TME). A randomized controlled trial has confirmed the efficacy and safety of Shen-Bai-Jie-Du decoction (SBJDD) in preventing colorectal ...

LAST 30 PRESS RELEASES:

How AI could speed the development of RNA vaccines and other RNA therapies

Scientists reveal how senses work together in the brain

Antarctica’s changing threat landscape underscores the need for coordinated action

Intergalactic experiment: Researchers hunt for mysterious dark matter particle with clever new trick

Using bacteria to sneak viruses into tumors

Large community heart health checks can identify risk for heart disease

Past Arctic climate secrets to be revealed during i2B “Into The Blue” Arctic Ocean Expedition 2025

Teaching the immune system a new trick could one day level the organ transplant playing field

Can green technologies resolve the “dilemma” in wheat production?

Green high-yield and high-efficiency technology: a new path balancing yield and ecology

How can science and technology solve the problem of increasing grain yield per unit area?

New CRISPR technique could rewrite future of genetic disease treatment

he new tech that could improve care for Parkinson's patients

Sharing is power: do the neighbourly thing when it comes to solar

Sparring saigas win 2025 BMC journals Image Competition

Researchers discover dementia-like behaviour in pre-cancer cells

Medical pros of electroconvulsive therapy (ECT) exaggerated while cons downplayed, survey findings suggest

Experts recommend SGLT-2 and GLP-1 diabetes drugs only for adults at moderate to higher risk of heart and kidney problems

Global study finds heart failure drug spironolactone fails to lower cardiovascular risk in dialysis patients

Deprivation and transport density linked to increased suicide risk in England

Flatworms can replace rats for breakthrough brain studies

Plastic from plants: FAMU-FSU College of Engineering professor uses material in plant cell walls to make versatile polymer

Leaders at Huntsman Cancer Institute drive theranostics expansion to transform cancer care

Thin films, big science: FSU chemists expand imaging possibilities with new X-ray material

66th Supplement to the Check-list of North American Birds publishes today in Ornithology

Canadian crops beat global emissions—even after 17 trips across the Atlantic

ORC2 regulation of human gene expression shows unexpected breadth and scale

Researchers track how iron deficiency disrupts photosynthesis in crucial ocean algae

A Mount Sinai-Led team creates model for understanding how the brain’s decision-making is impacted in psychiatric disorders

A new way to study omega fatty acids

[Press-News.org] Osteoporosis treatment benefits people older than 80
Medication reduces hospitalization, mortality risk among older patients